BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 91023)

  • 1. Combined use of guar and acarbose in reduction of postprandial glycaemia.
    Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson D; Alberti KG
    Lancet; 1979 Nov; 2(8149):924-7. PubMed ID: 91023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition.
    Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson DL; Misiewicz JJ; Alberti KG
    Am J Gastroenterol; 1988 Apr; 83(4):393-7. PubMed ID: 2831707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
    Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
    Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
    Dimitriadis GD; Tessari P; Go VL; Gerich JE
    Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.
    O'Dea K; Turton J
    Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glycoside-hydrolase inhibitor in treatment of dumping syndrome.
    McLoughlin JC; Buchanan KD; Alam MJ
    Lancet; 1979 Sep; 2(8143):603-5. PubMed ID: 90270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
    Hillebrand I; Aubell R; Boehme K; Bloom SR; Berchtold P
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unabsorbable carbohydrates and diabetes: Decreased post-prandial hyperglycaemia.
    Jenkins DJ; Goff DV; Leeds AR; Alberti KG; Wolever TM; Gassull MA; Hockaday TD
    Lancet; 1976 Jul; 2(7978):172-4. PubMed ID: 73796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guar flour in the treatment of diabetes mellitus].
    Porciatti F
    G Clin Med; 1979 Nov; 60(11):927-30. PubMed ID: 232683
    [No Abstract]   [Full Text] [Related]  

  • 11. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR; Ebert R; Creutzfeldt W
    Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of unabsorbable carbohydrate on gut hormones. Modification of post-prandial GIP secretion by guar.
    Morgan LM; Goulder TJ; Tsiolakis D; Marks V; Alberti KG
    Diabetologia; 1979 Aug; 17(2):85-9. PubMed ID: 488570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acarbose--a new therapeutic principle in diabetes mellitus therapy].
    Schöffling K; Hillebrand I
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1083-4. PubMed ID: 6114844
    [No Abstract]   [Full Text] [Related]  

  • 14. Guar gum, dietary fiber and diabetes.
    Med Lett Drugs Ther; 1979 Jun; 21(12):51-2. PubMed ID: 449840
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Thomas G; Puls W
    Metabolism; 1982 Jul; 31(7):710-4. PubMed ID: 7045575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guar gum is not a panacea in diabetes management.
    Carroll DG; Dykes V; Hodgson W
    N Z Med J; 1981 May; 93(683):292-4. PubMed ID: 6265843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study.
    Ruppin H; Hagel J; Feuerbach W; Schutt H; Pichl J; Hillebrand I; Bloom S; Domschke W
    Gastroenterology; 1988 Jul; 95(1):93-9. PubMed ID: 3286363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary guar gum improves insulin sensitivity in streptozotocin-induced diabetic rats.
    Cameron-Smith D; Habito R; Barnett M; Collier GR
    J Nutr; 1997 Feb; 127(2):359-64. PubMed ID: 9039840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
    Gérard J; Luyckx AS; Lefebvre PJ
    Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses.
    Requejo F; Uttenthal LO; Bloom SR
    Diabet Med; 1990 Jul; 7(6):515-20. PubMed ID: 2163805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.